Inhibition of the enzymatic activity of HDAC-1 and
likely HDAC-2 and 3 by synthetic inhibitors of HDACs
(HDACi) leads to activation of the HIV-1 LTR and HIV-1 gene
expression. Moreover, unlike cell activators of NFkB, such as
IL-2, OKT3, or TNFa, HDACi facilitate gene expression
without general activation cytokines and the T cell